GRANDE Trademark

Trademark Overview

On Tuesday, April 30, 2019, a trademark application was filed for GRANDE with the United States Patent and Trademark Office. The USPTO has given the GRANDE trademark a serial number of 88409581. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by Kashiv BioSciences, LLC. The GRANDE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services for providing gastro-retentive drug delivery systems that provide delayed release, delayed controlled release, delayed extended release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients, release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients
grande

General Information

Serial Number88409581
Word MarkGRANDE
Filing DateTuesday, April 30, 2019
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6428821
Registration DateTuesday, July 20, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements

Goods and ServicesPharmaceutical research and development services for providing gastro-retentive drug delivery systems that provide delayed release, delayed controlled release, delayed extended release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients, release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients
Translation of Words in MarkThe English translation of "GRANDE" in the mark is "BIG".

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 17, 2019
Primary Code042
First Use Anywhere DateMonday, July 1, 2019
First Use In Commerce DateMonday, July 1, 2019

Trademark Owner History

Party NameKASHIV SPECIALTY PHARMACEUTICALS, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBRIDGEWATER, NJ 08807
Party NameKASHIV SPECIALTY PHARMACEUTICALS, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressBRIDGEWATER, NJ 08807
Party NameKashiv BioSciences, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameKashiv BioSciences, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 14, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 11, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 12, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 12, 2021FINAL REFUSAL E-MAILED
Friday, February 12, 2021SU - FINAL REFUSAL - WRITTEN
Tuesday, January 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 11, 2021ASSIGNED TO LIE
Friday, January 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, October 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 14, 2020USE AMENDMENT FILED
Friday, October 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 14, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, September 30, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 15, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, July 15, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, July 15, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Monday, July 15, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, July 11, 2019ASSIGNED TO EXAMINER
Thursday, May 23, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, May 21, 2019ASSIGNED TO LIE
Friday, May 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 14, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, May 3, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

grande release controlled delayed pharmaceutical corresponding circadian ingredients active rhythms biological